The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.

作者: Jeffrey H. Burton , Julia Garcia-Diaz , Leonardo Seoane , Leonardo Seoane , Eboni G. Price-Haywood

DOI: 10.1016/J.CMI.2020.12.029

关键词:

摘要: Abstract Objective While many seroprevalence studies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been performed, few are demographically representative. This investigation focused on defining the nature and frequency symptomatic asymptomatic SARS-CoV-2 infection in a representative, cross-sectional sample communities Louisiana, USA. Methods A 4778 adults from New Orleans Baton Rouge, Louisiana were given survey symptoms co-morbidities, nasopharyngeal swab to test for active (PCR), blood draw past (IgG). Odds ratios, cluster analysis, quantification virus antibody, linear modelling used understand whether certain associated with positive test, how grouped together, or antibody varied by symptom status, being was different across age span. Results Reported anosmia/ageusia strongly test; 40.6% (93/229) tested versus 4.8% (218/4549) positivity those who did not report (OR 13.6, 95% CI 10.1–18.3). Of people positive, 47.3% (147/311) completely asymptomatic. Symptom presentation clustered into three groups; low/no (0.4 ± 0.9, mean ± SD), highly (7.5 ± 1.9) moderately (4.0 ± 1.5). Quantity lower group (cycle number 23.3 ± 8.3 17.3 ± 9.0; p  Conclusion Anosmia/ageusia can be differentiate other illnesses, and, high ratio individuals, contact tracing should include without symptoms. Regular testing congregant settings over 60 years may help mitigate spread.

参考文章(32)
Eran Bendavid, Bianca Mulaney, Neeraj Sood, Soleil Shah, Emilia Ling, Rebecca Bromley-Dulfano, Cara Lai, Zoe Weissberg, Rodrigo Saavedra-Walker, Jim Tedrow, Dona Tversky, Andrew Bogan, Thomas Kupiec, Daniel Eichner, Ribhav Gupta, John P.A. Ioannidis, Jay Bhattacharya, COVID-19 Antibody Seroprevalence in Santa Clara County, California medRxiv. ,(2020) , 10.1101/2020.04.14.20062463
Asako Doi, Kentaro Iwata, Hirokazu Kuroda, Toshikazu Hasuike, Seiko Nasu, Aya Kanda, Tomomi Nagao, Hiroaki Nishioka, Keisuke Tomii, Takeshi Morimoto, Yasuki Kihara, Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study. medRxiv. ,(2020) , 10.1101/2020.04.26.20079822
Andrew Bryan, Gregory Pepper, Mark H. Wener, Susan L. Fink, Chihiro Morishima, Anu Chaudhary, Keith R. Jerome, Patrick C. Mathias, Alexander L. Greninger, Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. Journal of Clinical Microbiology. ,vol. 58, ,(2020) , 10.1128/JCM.00941-20
Christian Erikstrup, Christoffer Egeberg Hother, Ole Birger Vestager Pedersen, Kåre Mølbak, Robert Leo Skov, Dorte Kinggaard Holm, Susanne Sækmose, Anna Christine Nilsson, Patrick Terrence Brooks, Jens Kjærgaard Boldsen, Christina Mikkelsen, Mikkel Gybel-Brask, Erik Sørensen, Khoa Manh Dinh, Susan Mikkelsen, Bjarne Kuno Møller, Thure Haunstrup, Lene Harritshøj, Bitten Aagaard Jensen, Henrik Hjalgrim, Søren Thue Lillevang, Henrik Ullum, Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors medRxiv. ,(2020) , 10.1101/2020.04.24.20075291
Hendrik Streeck, Bianca Schulte, Beate M. Kümmerer, Enrico Richter, Tobias Höller, Christine Fuhrmann, Eva Bartok, Ramona Dolscheid, Moritz Berger, Lukas Wessendorf, Monika Eschbach-Bludau, Angelika Kellings, Astrid Schwaiger, Martin Coenen, Per Hoffmann, Birgit Stoffel-Wagner, Markus M. Nöthen, Anna-Maria Eis-Hübinger, Martin Exner, Ricarda Maria Schmithausen, Matthias Schmid, Gunther Hartmann, Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event medRxiv. ,(2020) , 10.1101/2020.05.04.20090076
Maryam Shakiba, Seyed Saeed Hashemi Nazari, Fardin Mehrabian, Seyed Mahmoud Rezvani, Zahra Ghasempour, Abtin Heidarzadeh, Seroprevalence of COVID-19 virus infection in Guilan province, Iran medRxiv. ,(2020) , 10.1101/2020.04.26.20079244
Luca Valenti, Annalisa Bergna, Serena Pelusi, Federica Facciotti, Alessia Lai, Maciej Tarkowski, Alessandra Berzuini, Flavio Caprioli, Luigi Santoro, Guido Baselli, Carla Della Ventura, Elisa Erba, Silvano Bosari, Massimo Galli, Gianguglielmo Zehender, Daniele Prati, SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak medRxiv. ,(2020) , 10.1101/2020.05.11.20098442
Neeraj Sood, Paul Simon, Peggy Ebner, Daniel Eichner, Jeffrey Reynolds, Eran Bendavid, Jay Bhattacharya, None, Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. JAMA. ,vol. 323, pp. 2425- 2427 ,(2020) , 10.1001/JAMA.2020.8279
Maher A. Sughayer, Asem Mansour, Abeer Al Nuirat, Lina Souan, Mohammad Ghanem, Mahmoud Siag, Covid-19 Seroprevalence rate in healthy blood donors from a community under strict lockdown measures medRxiv. ,(2020) , 10.1101/2020.06.06.20123919
Cristiana Costa Gomes, Crispim Cerutti, Eliana Zandonade, Ethel Leonor Noia Maciel, Filomena Euridice Carvalho de Alencar, Gilton Luiz Almada, Orlei Amaral Cardoso, Pablo Medeiros Jabor, Raphael Lubiana Zanotti, Tania Queiroz Reuter, Vera Lucia Gomes de Andrade, Whisllay Maciel Bastos, Nésio Fernandes de Medeiros, A population-based study of the prevalence of COVID-19 infection in Espirito Santo, Brazil: methodology and results of the first stage medRxiv. ,(2020) , 10.1101/2020.06.13.20130559